|
NUDT9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.27737836869346E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.25199883583127E-11 |
| Normal-vs-Stage2 |
5.552400E-02 |
| Normal-vs-Stage3 |
1.65600866353088E-12 |
| Normal-vs-Stage4 |
1.86806126123429E-12 |
| Stage1-vs-Stage2 |
5.518900E-03 |
| Stage1-vs-Stage3 |
5.964400E-03 |
| Stage1-vs-Stage4 |
5.203700E-03 |
| Stage2-vs-Stage3 |
3.55950000000549E-05 |
| Stage2-vs-Stage4 |
3.66800000000111E-05 |
| Stage3-vs-Stage4 |
6.246800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.66293670342566E-15 |
| Normal-vs-AfricanAmerican |
3.54959999999682E-05 |
| Normal-vs-Asian |
2.034400004014E-08 |
| Caucasian-vs-AfricanAmerican |
9.274600E-01 |
| Caucasian-vs-Asian |
1.388800E-01 |
| AfricanAmerican-vs-Asian |
3.446000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14579457033415E-11 |
| Normal-vs-Female |
7.02216063075412E-13 |
| Male-vs-Female |
7.928200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.87172499721555E-12 |
| Normal-vs-Age(41-60Yrs) |
3.8796965640131E-11 |
| Normal-vs-Age(61-80Yrs) |
2.22950546913125E-11 |
| Normal-vs-Age(81-100Yrs) |
6.348000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.298400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.523800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.897200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.486600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.210800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.476200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.43130000074265E-08 |
| Classical-VS-Follicular |
3.109299995252E-08 |
| Classical-VS-Other |
2.533800E-01 |
| Classical-VS-Normal |
1.63624669369256E-12 |
| Tall-VS-Follicular |
2.22044604925031E-16 |
| Tall-VS-Other |
8.337600E-03 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
3.611600E-01 |
| Follicular-VS-Normal |
7.347600E-02 |
| Other-VS-Normal |
2.539600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94739999681559E-08 |
| Normal-vs-N1 |
1.31006316905768E-14 |
| N0-vs-N1 |
6.06690000000132E-05 |
|
|
